How many patents does
Oryzon Genomics have?
patents
309
families
41
granted
58
applications
251
US
65
WO
51
EP
35
JP
15
CN
14
KR
12
RoW
117
Buy the report
The report contains ten-year analysis with the following sections
- patent filing analysis
- worldwide filing analysis
- patent family analysis
- application analysis
- granted analysis
- classification analysis
- citation analysis
contact us for pricing
- VAT will apply to UK companies
- EU companies must supply their VAT number
Check out our sample pages |
Find companies to compare
Many companies now available
companies
12,000+
patents
42 million
patent families
23 million
Search to find companies of interest
read summary of their published patent
the following tables are just extracts from the report
the company report contains more information
Oryzon Genomics
Top ten assignees appearing on patents
2009 - 2018
| oryzon genomics | 253 |
| roche | 16 |
| crystax pharmaceuticals, s.l. | 2 |
| oryzon gnomics | 1 |
| oryzong genomics | 1 |
| oryzon fenomics | 1 |
2009
| oryzon genomics | 13 |
| crystax pharmaceuticals, s.l. | 1 |
2018
| oryzon genomics | 44 |
| roche | 3 |
Oryzon Genomics
The top ten patent families are
|
Title of patent family (most common patent title) |
Family members |
Filing year |
|---|---|---|
| (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors | 38 | 2011 |
| lysine specific demethylase-1 inhibitors and their use | 32 | 2010 |
| arylcyclopropylamine based demethylase inhibitors of lsd1 and their medical use | 32 | 2010 |
| (hetero)aryl cyclopropylamine compounds as lsd1 inhibitors | 28 | 2011 |
| lysine specific demethylase-1 inhibitors and their use | 21 | 2009 |
| biomarkers associated with lsd1 inhibitors and uses thereof | 16 | 2015 |
| solid forms | 13 | 2015 |
| lysine demethylase inhibitors for diseases and disorders associated with hepadnaviridae | 12 | 2010 |
| molecular diagnostic method and treatment in dementia with lewy bodies | 8 | 2004 |
| combinations of lsd1 inhibitors for the treatment of hematological malignancies | 8 | 2016 |